Skip to content
Thursday, October 29, 2026 · Today’s edition, 6:30 a.m. ETThu, Oct 29 · 6:30 a.m. editionSign inMy Desk 0EditionsSign in

Who holds ELVNENLIVEN THERAPEUTICS

8 funds on our shelf carry ENLIVEN THERAPEUTICS — heaviest hand: XPH at 2.09% of its book.

FundWeightFund assetsShares held
XPHState Street SPDR S&P Pharmaceuticals ETFINDEX2.09%$487M176,696
IHEiShares U.S. Pharmaceuticals ETFINDEX0.58%$1.6B215,440
DWASInvesco Dorsey Wright SmallCap Momentum ETFINDEX0.36%$411M33,302
IBBQInvesco Nasdaq Biotechnology ETFINDEX0.20%$112M5,627
IBBiShares Biotechnology ETFINDEX0.18%$10.6B466,924
IWOiShares Russell 2000 Growth ETFINDEX0.17%$14.4B546,593
VTWGVanguard Russell 2000 Growth ETFINDEX0.17%$1B63,471
VHTVanguard Health Care Index FundINDEX0.03%$19B147,291

LATEST DISCLOSED BOOKS ON THE ENRICHED SHELF · THE SHELF GROWS NIGHTLY AS READERS RESEARCH NEW FUNDS

ETF Dailyfrom Private Wealth Daily

ETF launches, fund research, and market coverage in your inbox every morning. Free.

Free. Every morning. Unsubscribe from any edition in one click.